Recent Quotes (30 days)

You have no recent quotes
chg | %

Nanollose Ltd  

(Public, ASX:NC6)   Watch this stock  
Find more results for NC6
-0.010 (-5.88%)
Jan 18 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.16 - 0.17
52 week 0.16 - 0.38
Open 0.17
Vol / Avg. 93,001.00/208,635.00
Mkt cap 5.60M
P/E     -
Div/yield     -
EPS     -
Shares 50.00M
Beta     -
Inst. own     -

Key stats and ratios

Net profit margin - -54690.00%
Operating margin - -54668.00%
EBITD margin - -44318.67%
Return on average assets - -1014.91%
Return on average equity - -
CDP Score - -


Cpc, U 5 145 Stirling Hwy
+61-8-93893180 (Phone)

Website links


Nanollose Limited is an Australia-based biotechnology company. The Company is focused on discovering, developing and commercializing novel products and processes related to microbial nanocellulose. It has developed a proprietary technology for production, processing and applications of microbial nanocellulose called the Plant-free cellulose technology. Its technology modifies the structure of nanocellulose by physical or chemical treatments to produce novel modified fibers or other materials. It seeks to commercialize the production and use of Plant-Free cellulose as an alternative to cotton, tree pulp and other materials used in the textile industry. It has also identified applications in the horticulture industry, specifically for seed germination. It also serves other industries, including medical applications, personal hygiene markets, materials such as paper, packaging and cardboard, biodegradable plastic and films, and food applications, such as food supplements.